Press Releases

Report Date Files
Portage Completes Non-Brokered Private Placement for Total Proceeds of US$2,000,000 16 October 2014 Click to open
Portage Announces Additional Consultants to Expedite its PPL-003 Development Programs 06 October 2014 Click to open
Portage Announces Conversion of Its Debt into Equity 29 September 2014 Click to open
Portage Announces New Consultants for its PPL-003 Development Programs 23 September 2014 Click to open
Portage Announces Proposed Private Placement 11 September 2014 Click to open
Portage's Biohaven Granted United States Patent for Glutamate Agents in the Treatment of Mental Disorders 06 August 2014 Click to open
Portage Announces Successful Validation of its New Proprietary Cell Permeable Peptide Platform Technology 14 July 2014 Click to open
Portage Signs a Collaborative Research and Development Agreement with U.S. National Institute of Health 15 May 2014 Click to open
Portage's Biohaven Issued Notice of Allowance: Glutamate Agents in the Treatment of Mental Disorders 05 May 2014 Click to open
Portage Provides Updates 10 April 2014 Click to open
Yale University Reports on Biohaven 03 March 2014 Click to open
Portage Reports Third Quarter Financial Results and Provides Updates 25 February 2014 Click to open
Portage Acquires Majority Interest in Biohaven Pharmaceutical Holding Company Limited 06 January 2014 Click to open
Portage Lauches New Website and Provides Update on its R&D Activities 17 December 2013 Click to open
Correction to October 25th Release 28 October 2013 Click to open